AzTrials
AzTrials

Procedural SedationTEMPONCT07763860

Therapeutic Effects of Music on Procedural Outcomes

A study testing Low-Tempo Instrumental Music in people with Procedural Sedation and Gastrointestinal Endoscopy, run by Bahaa Bou Dargham at 1 site in Lebanon.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will evaluate whether listening to low-tempo instrumental music during gastroscopy and/or colonoscopy can reduce the amount of sedative medication needed during the procedure. Adults undergoing elective gastroscopy and/or colonoscopy with sedation will be randomly assigned to one of two groups. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Low-Tempo Instrumental Music
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
180 participants
Where
1 siteLebanon
Study dates
Aug 2026to Oct 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥18 years.
  • Scheduled for elective gastroscopy (upper gastrointestinal endoscopy), colonoscopy, or both under procedural sedation.
  • Able to provide written informed consent.

Who cannot join

  • Emergency or urgent endoscopic procedure.
  • Hearing impairment that prevents adequate perception of the standardized test audio through the study headphones.
  • American Society of Anesthesiologists (ASA) Physical Status IV or higher.
  • Cognitive impairment, altered mental status, or another condition that prevents provision of informed consent or reliable completion of study assessments.
  • Any condition that prevents safe or appropriate use of the study headphones.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Bahaa W Bou Dargham, MD contact

+961 3 537 986

bahaa_boudargham@hotmail.com

Lebanon1 site, 1 recruiting
  • Hammoud Hospital University Medical Center (HHUMC)

    Sidon

    Ghada Aoun, +961 7 723 111 ext. 1956, medical@hhumc.org.lb

    Bahaa W Bou Dargham, MD

    Recruiting

Other trials in Lebanon

About this study

Official title: Effect of Intra-Procedural Low-Tempo Instrumental Music Plus Standard Sedation Versus Standard Sedation Alone on Sedative Requirements in Adults Undergoing Gastroscopy and/or Colonoscopy: a Single-Center, Parallel-Group, Randomized Superiority Trial With Blinded Outcome Assessors and Statisticians

This study will evaluate whether listening to low-tempo instrumental music during gastroscopy and/or colonoscopy can reduce the amount of sedative medication needed during the procedure. Adults undergoing elective gastroscopy and/or colonoscopy with sedation will be randomly assigned to one of two groups. One group will listen to low-tempo instrumental music (60-80 beats per minute) through headphones during the procedure in addition to receiving standard sedation. The other group will receive standard sedation without music.

The main outcome of the study is the amount of sedative medication required during the procedure. The study will also compare pain after the procedure, time until discharge, patient satisfaction, and changes in heart rate and blood pressure between the two groups. The researchers hypothesize that patients who listen to low-tempo music will require less sedative medication and may have improved recovery and patient-reported outcomes compared with patients receiving standard sedation alone.

Read the detailed description

Gastroscopy and colonoscopy are commonly performed procedures that may be associated with anxiety, discomfort, and the need for procedural sedation. Greater exposure to sedative medications may contribute to delayed recovery and sedation-related adverse effects. Non-pharmacological interventions that promote relaxation and improve patient comfort may therefore be useful adjuncts to routine endoscopic care. Music is a simple, low-cost intervention that may reduce physiologic arousal and improve the procedural experience. Low-tempo instrumental music can also be standardized and delivered without interfering with routine clinical care.

TEMPO is a single-center, randomized, parallel-group superiority trial evaluating the effect of intra-procedural low-tempo instrumental music in adults undergoing elective gastroscopy and/or colonoscopy with sedation. Participants will be randomly assigned in a 1:1 ratio to either low-tempo instrumental music in addition to standard sedation or standard sedation alone. In the intervention group, instrumental music with a tempo of 60-80 beats per minute will be delivered through headphones during the endoscopic procedure. In the control group, participants will wear the same headphones and an assigned silent audio file will be played. Sedation and all other aspects of clinical care will otherwise follow routine practice and clinical judgment in both groups.

A standardized masking procedure will be used for both groups. Before the procedure, all participants will have headphones applied and a short test audio will be played to confirm that the headphones are functioning correctly and to adjust the volume to a comfortable level. This pre-procedure test will be performed before the participant's treatment allocation is revealed through the study system.

Randomization and allocation concealment will be managed independently from participant enrollment and intervention delivery. The allocation sequence and the correspondence between study participants, treatment groups, and assigned audio files will be maintained by an independent individual who is not involved in participant recruitment, intervention delivery, outcome assessment, or statistical analysis. Research personnel enrolling participants will not have access to the allocation sequence.

At the time of study enrollment, the researcher will access a dedicated study platform and obtain an audio file assigned specifically to that participant. Each file will have a unique one-time identifier and filename. The researcher will download the assigned file, apply the headphones, and initiate playback without knowing whether the file contains low-tempo music or silence. For participants randomized to the intervention group, the file will contain the standardized low-tempo instrumental music. For participants randomized to the control group, the file will contain a silent audio track. Playback will appear and progress in the same manner in both groups. Unique filenames and identifiers will be used so that previous assignments cannot be used to infer current or future treatment allocation.

Before the procedure, baseline demographic and clinical information, and vital signs will be recorded. During the procedure, sedative medication use and physiologic parameters will be documented. Following the procedure, recovery and patient-reported outcomes will be assessed, including pain, satisfaction with the endoscopic experience, and time to discharge. The primary objective is to determine whether intra-procedural exposure to low-tempo instrumental music reduces sedative medication requirements compared with standard sedation alone. Secondary analyses will evaluate postoperative pain, recovery time, patient satisfaction, and physiologic outcomes.

Research personnel responsible for postoperative outcome assessment will remain unaware of treatment allocation. Participants will be instructed not to disclose whether they heard music during the procedure until all masked postoperative outcome assessments have been completed. Outcome assessors will not ask participants questions that could reveal their allocation before these assessments are completed. The statistical analysis will also be conducted using coded treatment groups, with the treatment code withheld from the statistician until the prespecified analysis has been completed.

Because participants may perceive whether music was present during the procedure, participant masking cannot be guaranteed despite the identical headphone setup and standardized procedures used in both groups. The masking strategy is primarily designed to prevent investigators, personnel responsible for intervention delivery, postoperative outcome assessors, and the statistician from knowing treatment allocation during the relevant stages of the trial.

The study is being conducted at Hammoud Hospital University Medical Center (HHUMC) in Saida, Lebanon. The music intervention does not replace or modify standard procedural sedation and is evaluated as an adjunct to usual endoscopic care. The findings may help determine whether a simple, inexpensive, and readily implementable intervention can reduce sedative requirements and improve recovery and patient-centered outcomes in adults undergoing gastrointestinal endoscopy.

Being tested
Low-Tempo Instrumental Music, Silent Audio Control
Keywords
Music, Low-Tempo Music, Gastroscopy, Colonoscopy, Procedural Sedation, Sedation, Propofol, Pain, Patient Satisfaction, Recovery Time
Medical subject headings
Pain, Patient Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low-Tempo Instrumental MusicOther

    Standardized instrumental music with a tempo of 60-80 beats per minute will be delivered through headphones during the endoscopic procedure. Playback will begin after application of the headphones and continue throughout the procedure. The intervention is provided in addition to standard procedural sedation.

  • Silent Audio ControlOther

    A silent audio file will be delivered through identical headphones during the endoscopic procedure. The file will play and progress in the same manner as the active music file but will contain no audible music. The control procedure is provided in addition to standard procedural sedation.

Study groups in NCT07763860
Study groupRoleWhat they receive
Low-Tempo Music InterventionExperimentalParticipants will receive standard procedural sedation and will listen to low-tempo instrumental music (60-80 beats per minute) through headphones throughout the gastroscopy and/or colonoscopy. Before randomization, headphones will be tested using a standardized test audio and the volume will be adjusted to a comfortable level. During the procedure, a uniquely identified audio file containing the study music will be played by masked research personnel.
Receives: Other: Low-Tempo Instrumental Music
Silent Audio ControlSham comparatorParticipants will receive standard procedural sedation and will wear identical headphones throughout the gastroscopy and/or colonoscopy. Before randomization, headphones will be tested using the same standardized test audio and the volume will be adjusted to a comfortable level. During the procedure, a uniquely identified silent audio file will be played by masked research personnel. The audio player will progress in the same manner as in the intervention group.
Receives: Other: Silent Audio Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean Total Propofol Dose Requirement During the Endoscopic Procedure

    Total propofol dose administered to each participant during procedural sedation will be calculated as the cumulative dose administered from the start of sedation until the end of the gastroscopy and/or colonoscopy and normalized to body weight (mg/kg). The mean total propofol dose in mg/kg will be compared between the randomized groups.

    Measured: From first administration of procedural sedation until the end of the endoscopic procedure on the day of enrollment

Secondary outcomes (4)
  1. Mean Post-Procedural Pain Intensity on the 0-10 Numeric Rating Scale

    Pain intensity will be assessed using an 11-point Numeric Rating Scale (NRS) ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Mean NRS scores will be compared between randomized groups at each prespecified post-procedure assessment.

    Measured: 10 minutes after entry to the recovery room and immediately before discharge from the recovery room

  2. Mean Time From End of Procedure to Recovery Room Discharge

    Recovery time will be calculated in minutes from the end of the endoscopic procedure, defined as the time the participant is detached from procedural monitoring, until the participant exits the recovery room. Mean recovery time will be compared between randomized groups.

    Measured: From end of the endoscopic procedure until exit from the recovery room

  3. Overall Patient Satisfaction With the Endoscopic Procedure

    Overall patient satisfaction will be assessed using the custom item, "Overall, I am satisfied with the procedure I underwent." Responses will be recorded on a 4-point Likert scale: 1 = strongly disagree, 2 = disagree, 3 = agree, and 4 = strongly agree. Higher scores indicate greater satisfaction.

    Measured: Before discharge from the recovery room on the day of the procedure

  4. Requirement for Rescue Analgesia in the Recovery Room

    The requirement for rescue analgesia will be assessed from entry into the recovery room until recovery room discharge. The proportion of participants receiving at least one analgesic medication for post-procedural pain will be compared between the randomized groups. The analgesic medication administered and its dose will also be recorded.

    Measured: From entry into the recovery room until recovery room discharge on the day of the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2026
  2. Study startAug 2026 (estimated)
  3. Primary completionOct 2026 (estimated)
  4. Study completionOct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomized in a 1:1 ratio to two parallel groups: low-tempo instrumental music (60-80 beats per minute) delivered through headphones during the endoscopic procedure in addition to standard sedation, or a control group receiving standard sedation with an identically administered silent audio file through headphones. Each participant will remain in the assigned group for the duration of the study.
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07763860
Sponsor's protocol ID
IRB-July2026-VII
Acronym
TEMPO
Status last verified
Aug 2026
First submitted
9 Aug 2026
Last updated
13 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data are not currently planned to be shared with external researchers because the approved study protocol limits access to study data to investigators directly involved in the study. De-identified aggregate study results will be disseminated through the trial registry, scientific presentations, and peer-reviewed publication.

Questions about this trial

What is this clinical trial studying?

A study testing Low-Tempo Instrumental Music in people with Procedural Sedation and Gastrointestinal Endoscopy, run by Bahaa Bou Dargham at 1 site in Lebanon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Lebanon. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Bahaa W Bou Dargham, MD (+961 3 537 986, bahaa_boudargham@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean Total Propofol Dose Requirement During the Endoscopic Procedure (time frame: From first administration of procedural sedation until the end of the endoscopic procedure on the day of enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in